Novogene

Executive Summary

Novogene is a leading global provider of genomic services and solutions headquartered in Beijing, China. Founded in 2011, the company specializes in high-throughput sequencing, bioinformatics analysis, and clinical diagnostics, serving academic, pharmaceutical, and clinical research institutions worldwide. With over 1,000 employees and a strong presence in both domestic and international markets, Novogene has established itself as a key player in the genomics and diagnostics sectors. The company is publicly traded and continues to expand its service portfolio, leveraging advanced technologies to support a wide range of genomic applications, from basic research to precision medicine.

Upcoming Catalysts (preview)

• Q3 2026Launch of Enhanced Clinical Sequencing Panel for Oncology75% success
• Q4 2026Strategic Partnership with Major Pharmaceutical Company for Genomic Data Analysis60% success
• Q2 2027Release of Next-Generation Sequencing Platform with Improved Throughput50% success